15 rezultati
To report an unusual case of early macular necrosis in acute retinal necrosis and its features on multimodal imaging.Findings on fundus examination, laboratory workup, fluorescein angiography, autofluorescence, optical coherence tomography, and optical OBJECTIVE
Demyelinizing neurological disease is a rare complication after treatment with tumor necrosis factor (TNF)α antagonists. We report on a case of multiple sclerosis after TNFα antagonist treatment and discuss its differential diagnosis.
METHODS
This is an observational case study.
RESULTS
A
OBJECTIVE
To review the neuro-ophthalmological and radiological findings of acute methyl alcohol intoxication.
METHODS
8 acute methyl alcohol intoxication cases were evaluated.
RESULTS
All patients were male and their ages varied between 21 and 55. At the initial examination, 6 to 12 days after
BACKGROUND
New data on foam sclerotherapy of varicose veins has been recently published.
OBJECTIVE
To identify the current treatment modalities and their effectiveness in use of foam sclerotherapy.
METHODS
Review of the recent literature regarding clinical treatment of varicose veins using foam
Macular edema is a common feature of posterior segment diseases. It is an expression of abnormal permeability in either retinal vessels (inner blood-retinal barrier) or in the retinal pigment epithelium (outer blood-retinal barrier). It occurs in either a diffuse pattern where the macula appears
1. Cytomegalovirus retinitis is the leading cause of AIDS-related blindness. 2. Patients with reduced CD4 counts are at risk of developing cytomegalovirus retinitis and should be informed of symptoms (floaters, scotoma) and should have periodic dilated retina examinations. 3. AIDS patients who
Three patients with acute monocular central scotoma and headache had the initial diagnosis of optic neuritis. Computed tomography showed large pituitary adenomas with necrosis and cyst formation consistent with the clinical symptoms of a previous pituitary apoplexy. After transsphenoidal
Selective retina therapy (SRT) is currently under evaluation, as a new and very subtle laser method, for the treatment of retinal disorders associated with a degradation of the retinal pigmentary epithelium (RPE). SRT makes it possible to selectively effect the RPE, sparing the adjacent neural
to report a case of branch retinal artery occlusion in the acute phase, using optical coherence tomography to evaluate the morphologic changes. A 27 year-old man had a sudden superior scotoma in the right eye, with fundus examination compatible with inferior temporal branch retinal artery
Toxic optic neuropathies (TONs) often present with a gradual and bilateral decrease in visual acuity, scotomas and optic disc pallor. Obtaining an accurate history is the critical first step in determining the etiology of TONs.
This updated review contains a thorough analysis of the current
To report a case of overlapping choriocapillaritis that initially presented as multifocal choroiditis (MFC) but later showed features compatible with acute zonal occult outer retinopathy (AZOOR) resistant to standard immunosuppression that responded only to adalimumad therapy. A 41-year-old patient
OBJECTIVE
To report a case of Diffuse Subretinal Fibrosis (DSF) syndrome refractory to immunosuppressive therapy who was successfully treated with anti-tumor necrosis factor-alpha (TNF)-alpha monoclonal antibodies infliximab.
METHODS
Interventional case report.
METHODS
A 23-year-old male with
BACKGROUND
Sclerotherapy is defined as the targeted elimination of small vessels, varicose veins and vascular anomalies by the injection of a sclerosant. The aim of sclerotherapy is to damage the vessel wall and transform it into a fibrous cord that cannot be recanalized. It is a simple,
Optic neuropathy has been reported in association with the use of tumor necrosis factor-alpha antagonists such as etanercept, infliximab, and adalimumab. This is a report of a patient who began experiencing decreased vision approximately 1 month after starting infliximab therapy for rheumatoid
BACKGROUND
Recently a new method of using a foam sclerosing agent for the treatment of leg veins has been described. We present a pilot study of a new technique for producing the sclerosing foam (Tessari's method) (SFT) and its use in sclerotherapy of major and minor varicosities.
OBJECTIVE
A